Commonwealth Equity Services
DMRA

Commonwealth Equity Services’s Damora Therapeutics DMRA Stock Holding History

Commonwealth Equity Services’s Portfolio DMRA Stock Details DMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-641
Closed -$8K – 4123
2024
Q2 		$8K Sell
641
-259
-29% -$4.09K ﹤0.01% 4006
2024
Q1 		$18K Buy
900
+217
+32% +$3.86K ﹤0.01% 3968
2023
Q4 		$12K Sell
683
-42
-6% -$646 ﹤0.01% 3850
2023
Q3 		$13K Buy
725
+247
+52% +$9.7K ﹤0.01% 3765
2023
Q2 		$30K Buy
478
+71
+17% +$3.87K ﹤0.01% 3720
2023
Q1 		$20K Hold
407
– – ﹤0.01% 3668
2022
Q4 		$11K Hold
407
– – ﹤0.01% 3638
2022
Q3 		$19K Buy
+407
New +$20.6K ﹤0.01% 3585

Other funds holding DMRA

NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $50.6B AUM 42.84% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

Commonwealth Equity Services's DMRA Position: Q3 2024 in Review

Commonwealth Equity Services sold out of Damora Therapeutics (DMRA) in Q3 2024, closing a stake of 641 shares — an estimated $8K sold.

Commonwealth Equity Services first reported a position in DMRA in Q3 2022 and held it in 8 quarters. The position peaked at $30K in Q2 2023. 10 funds tracked by Wall St. Rank hold DMRA as of Q3 2024.

  • Commonwealth Equity Services reported no remaining Damora Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Commonwealth Equity Services sold 641 Damora Therapeutics shares in Q3 2024, an estimated $8K.
  • Commonwealth Equity Services first reported a position in Damora Therapeutics in Q3 2022 and held it in 8 quarters.
  • Commonwealth Equity Services's Damora Therapeutics position peaked at $30K in Q2 2023.
  • 10 funds tracked by Wall St. Rank held Damora Therapeutics as of Q3 2024.

Based on Commonwealth Equity Services's 13F filing for Q3 2024, filed 18 Oct 2024.